Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight ...
Recursion Pharmaceuticals (RXRX) just delivered encouraging Phase 1b/2 TUPELO data for its FAP drug candidate REC-4881, and that clinical update has quickly reshaped how both Wall Street and ...
If language is what makes us human, what does it mean now that large language models have gained “metalinguistic” abilities?
Wall Street ends 2026 positively with tech stocks dominating, but concerns over valuations drive interest in smaller AI ...
AI can help design AI systems: automating architecture choices, discovering algorithms, and optimizing hardware ...
The simulation hypothesis—the idea that our universe might be an artificial construct running on some advanced alien computer ...
The native just-in-time compiler in Python 3.15 can speed up code by as much as 20% or more, although it’s still experimental ...
Innovation fails when every pilot starts from scratch; the chassis approach shows how to move fast with vendors while keeping ...
REC-4881 (4 mg QD) achieved rapid clinical activity, with 75% of evaluable patients showing reductions in total polyp burden and a 43% median ...
Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last ...
Instead of a single, massive LLM, Nvidia's new 'orchestration' paradigm uses a small model to intelligently delegate tasks to a team of tools and specialized models.
Summary In this episode of The Defenders Log, Paul Mockapetris, the architect of DNS, discusses the evolving role of the Domain Name System from a simple directory to a sophisticated security tool. He ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback